Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Baclofen to Treat Gastroesophageal Reflux Disease in Children
TCTR20200415001Phase 1Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of baclofen in gastroesophageal reflux disease (GERD), sponsored by Golestan University of Medical Sciences. Started May 2019; status: completed.
02
Drugs
baclofen
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on TCTR20200415001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200415001.